IRVINE, Calif. (AP) _ Edwards Lifesciences Corp. (EW) on Wednesday reported third-quarter profit of $274.7 million.
The Irvine, California-based company said it had profit of $1.30 per share. Earnings, adjusted for non-recurring costs, were $1.41 per share.
The results exceeded Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $1.22 per share.
The medical device maker posted revenue of $1.09 billion in the period, which also beat Street forecasts. Ten analysts surveyed by Zacks expected $1.04 billion.
Edwards Lifesciences expects full-year earnings in the range of $5.50 to $5.65 per share, with revenue in the range of $4 billion to $4.3 billion.
Edwards Lifesciences shares have climbed 47% since the beginning of the year, while the Standard & Poor's 500 index has climbed 20%. In the final minutes of trading on Wednesday, shares hit $225.09, an increase of 52% in the last 12 months.